APA (APA) Financial statements
Company Profile
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|
| Total Revenue | |||||
| Cost of Revenue | |||||
| Gross Profit | |||||
| Gross Profit Margin (%) | |||||
| R&D Expense | |||||
| SG&A Expense | |||||
| Total Operating Expenses | |||||
| Operating Income or Loss | |||||
| Operating Margin (%) | |||||
| Interest Expense | |||||
| Total Other Income/Expenses | |||||
| Income Before Tax | |||||
| Income Tax Expense | |||||
| Income from Continuing Ops. | |||||
| Net Income | |||||
| Net Profit Margin (%) | |||||
| Net Income Available to Common Shareholders | |||||
| Basic EPS | |||||
| Diluted EPS | |||||
| Basic Average Shares | |||||
| Diluted Average Shares |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ||||||||||||||||||||
| Cost of Revenue | ||||||||||||||||||||
| Gross Profit | ||||||||||||||||||||
| Gross Profit Margin (%) | ||||||||||||||||||||
| R&D Expense | ||||||||||||||||||||
| SG&A Expense | ||||||||||||||||||||
| Total Operating Expenses | ||||||||||||||||||||
| Operating Income or Loss | ||||||||||||||||||||
| Operating Margin (%) | ||||||||||||||||||||
| Interest Expense | ||||||||||||||||||||
| Total Other Income/Expenses | ||||||||||||||||||||
| Income Before Tax | ||||||||||||||||||||
| Income Tax Expense | ||||||||||||||||||||
| Income from Continuing Ops. | ||||||||||||||||||||
| Net Income | ||||||||||||||||||||
| Net Profit Margin (%) | ||||||||||||||||||||
| Net Income Available to Common Shareholders | ||||||||||||||||||||
| Basic EPS | ||||||||||||||||||||
| Diluted EPS | ||||||||||||||||||||
| Basic Average Shares | ||||||||||||||||||||
| Diluted Average Shares |
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | |||||
| Marketable Securities | |||||
| Receivables | |||||
| Inventories | |||||
| Other Current Assets | |||||
| Total Current Assets | |||||
| Non-Current Assets | |||||
| Marketable Securities | |||||
| PPE Net | |||||
| Intangibles inc. Goodwill | |||||
| Other Non-Current Assets | |||||
| Total Non-Current Assets | |||||
| Total Assets | |||||
| Current Liabilities | |||||
| Accounts Payable | |||||
| Deferred Revenues | |||||
| Debt, Current | |||||
| Accrued Liabilities | |||||
| Other Current Liabilities | |||||
| Total Current Liabilities | |||||
| Non-Current Liabilities | |||||
| Deferred Revenues | |||||
| Debt, Non-Current | |||||
| Other Non-Current Liabilities | |||||
| Total Non-Current Liabilities | |||||
| Total Liabilities | |||||
| Shareholders' Equity | |||||
| Common Stock | |||||
| Additional Paid-In Capital | |||||
| Retained Earnings | |||||
| Other Shareholders' Equity | |||||
| Total Shareholders' Equity | |||||
| Total Liabilities & Shareholders' Equity |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash & Cash Equivalents | ||||||||||||||||||||
| Marketable Securities | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other Current Assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Non-Current Assets | ||||||||||||||||||||
| Marketable Securities | ||||||||||||||||||||
| PPE Net | ||||||||||||||||||||
| Intangibles inc. Goodwill | ||||||||||||||||||||
| Other Non-Current Assets | ||||||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts Payable | ||||||||||||||||||||
| Deferred Revenues | ||||||||||||||||||||
| Debt, Current | ||||||||||||||||||||
| Accrued Liabilities | ||||||||||||||||||||
| Other Current Liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Non-Current Liabilities | ||||||||||||||||||||
| Deferred Revenues | ||||||||||||||||||||
| Debt, Non-Current | ||||||||||||||||||||
| Other Non-Current Liabilities | ||||||||||||||||||||
| Total Non-Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Other Shareholders' Equity | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities & Shareholders' Equity |
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net Income | |||||
| Depreciation & Amortization | |||||
| Deferred Income Taxes | |||||
| Stock Based Compensation | |||||
| Accounts Receivable | |||||
| Inventory | |||||
| Accounts Payable | |||||
| Deferred Revenue | |||||
| Other Non-Cash | |||||
| Operating Cash Flow | |||||
| Cash Flows from Investing Activities | |||||
| PPE Investments | |||||
| Net Acquisitions | |||||
| Purchase of Investments | |||||
| Sale of Investments | |||||
| Other Investing Activity | |||||
| Investing Cash Flow | |||||
| Cash Flows from Financing Activities | |||||
| Debt Issued | |||||
| Proceeds from Debt Repayment | |||||
| Debt Repayment | |||||
| Proceeds from Sale of Equity | |||||
| Equity Repurchased | |||||
| Dividend Paid | |||||
| Other Financing Activity | |||||
| Financing Cash Flow | |||||
| Cash Position | |||||
| Beginning Cash Position | |||||
| End Cash Position | |||||
| Change in Cash | |||||
| Free Cash Flow | |||||
| Operating Cash Flow | |||||
| Capital Expenditure | |||||
| Free Cash Flow |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||||||||||||||||||
| Net Income | ||||||||||||||||||||
| Depreciation & Amortization | ||||||||||||||||||||
| Deferred Income Taxes | ||||||||||||||||||||
| Stock Based Compensation | ||||||||||||||||||||
| Accounts Receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Accounts Payable | ||||||||||||||||||||
| Deferred Revenue | ||||||||||||||||||||
| Other Non-Cash | ||||||||||||||||||||
| Operating Cash Flow | ||||||||||||||||||||
| Cash Flows from Investing Activities | ||||||||||||||||||||
| PPE Investments | ||||||||||||||||||||
| Net Acquisitions | ||||||||||||||||||||
| Purchase of Investments | ||||||||||||||||||||
| Sale of Investments | ||||||||||||||||||||
| Other Investing Activity | ||||||||||||||||||||
| Investing Cash Flow | ||||||||||||||||||||
| Cash Flows from Financing Activities | ||||||||||||||||||||
| Debt Issued | ||||||||||||||||||||
| Proceeds from Debt Repayment | ||||||||||||||||||||
| Debt Repayment | ||||||||||||||||||||
| Proceeds from Sale of Equity | ||||||||||||||||||||
| Equity Repurchased | ||||||||||||||||||||
| Dividend Paid | ||||||||||||||||||||
| Other Financing Activity | ||||||||||||||||||||
| Financing Cash Flow | ||||||||||||||||||||
| Cash Position | ||||||||||||||||||||
| Beginning Cash Position | ||||||||||||||||||||
| End Cash Position | ||||||||||||||||||||
| Change in Cash | ||||||||||||||||||||
| Free Cash Flow | ||||||||||||||||||||
| Operating Cash Flow | ||||||||||||||||||||
| Capital Expenditure | ||||||||||||||||||||
| Free Cash Flow |